Stay updated on Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. This appears to be a system/version update rather than a modification to the study content.
    Difference
    0.0%
    Check dated 2026-03-12T21:29:03.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.4.2 updated from v3.4.1; no visible changes to the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T03:48:59.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A minor software revision update was made from v3.4.0 to v3.4.1; there are no observable changes to study content, structure, or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T01:26:32.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Show glossary was added as a new UI toggle, and new metadata items 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a revision badge 'Revision: v3.4.0' have been introduced. Previously, the page displayed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T22:18:11.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A minor revision update was applied (v3.3.4). No changes to the study content or page layout are visible.
    Difference
    0.0%
    Check dated 2026-01-14T07:28:11.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a Tennessee location under Locations; the page revision updated to v3.3.3 and removed references to 'Tennessee Locations' and 'HHS Vulnerability Disclosure'.
    Difference
    0.2%
    Check dated 2025-12-24T02:23:58.000Z thumbnail image

Stay in the know with updates to Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial page.